As technology and genomic research progress, these diagnostics may become more accessible, enabling broader adoption across ...

Gopal released a statement saying insurance coverage must keep pace with advances in cancer treatment and by requiring state regulated insurers, including Medicaid, to cover biomarker testing ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Though lung cancer survival rates are improving, lung cancer is still the leading cause of cancer deaths in the US.

New research revealed tumor mutational burden was linked to improved event-free survival with pembrolizumab in early TNBC, ...

Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.

Legislation that would require health insurers to cover biomarker testing has advanced in the New Jersey State Senate. The measure, sponsored by Senators Troy Singleton and Vin Gopal, would ensure ...

Scientists at Aberystwyth University found that several key changes, or biomarkers, in the urine of men with prostate cancer ...